Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/29/1991 | DE4005684A1 Improving transformation efficiency of plants - by introducing a construct contg. cDNA fragment encoding luteovirus envelope protein |
08/29/1991 | CA2076975A1 Mammalian expression vectors |
08/29/1991 | CA2076849A1 Physiologically active substance well capable of permeating biomembrane |
08/29/1991 | CA2076665A1 Method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function |
08/29/1991 | CA2037199A1 Inhibitors of catalytic antibodies |
08/28/1991 | WO1991013152A1 SUBSTANTIALLY PURE TRANSFORMING GROWTH FACTOR-β1-BINDING PROTEIN AND NUCLEOTIDE SEQUENCES EXPRESSING THE BINDING PROTEIN |
08/28/1991 | WO1991013096A1 Method for detection of borrelia burgdorferi, purified antigen thereof and antibody capable of binding therewith |
08/28/1991 | EP0443880A2 Assay for equine infectious anemia virus |
08/28/1991 | EP0443874A2 Vectors and compounds for expression of glycosylation mutants of human protein C |
08/28/1991 | EP0443790A1 Growth hormone-like glycoproteins |
08/28/1991 | EP0443719A1 Novel R106 compounds |
08/28/1991 | EP0443718A2 Method for separation and concentration of phosphopeptides |
08/28/1991 | EP0443599A2 Monoclonal antibodies specific for tumor-associated antigens, method for their preparation and their use |
08/28/1991 | EP0443598A2 Peptides inhibiting the blood coagulation, their process of preparation and their use |
08/28/1991 | EP0443559A2 HIV protease inhibiting agents |
08/28/1991 | EP0443543A2 Novel lactic acid bacteria, antibacterial substance produced by the bacteria, fermented milk starter containing the bacteria, and process for producing fermented milk by using the starter |
08/28/1991 | EP0443532A2 Temporary minimal protection synthesis of LH-RH analogs |
08/28/1991 | EP0443429A1 Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin |
08/28/1991 | EP0443404A1 Peptide fragments and analogs of thrombospondin |
08/28/1991 | EP0443094A2 Non-biodegradable, two-phase corneal implant and method for preparing same |
08/28/1991 | EP0442926A1 Polypeptides |
08/28/1991 | EP0442916A1 Method for protein assembly using yeast heat shock protein 60 and analogs |
08/28/1991 | EP0267208B1 An insulin preparation for non-parenteral administration |
08/28/1991 | EP0198015B1 Production of streptavidin-like polypeptides |
08/28/1991 | EP0164403B1 Feline leukemia virus vaccine |
08/28/1991 | CN1054071A Orally active renin inhibitors |
08/28/1991 | CA2076855A1 Method for detection of borrelia burgdorferi, purified antigen thereof and antibody capable of binding therewith |
08/28/1991 | CA2036963A1 Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
08/27/1991 | WO1991013089A1 Peptide derivatives and production thereof |
08/27/1991 | US5043431 Method and apparatus for the production of TGF-β |
08/27/1991 | US5043430 Process for treating insoluble heterologous protein |
08/27/1991 | US5043429 Anticoagulant polypeptide |
08/27/1991 | US5043428 Using carbohydrate anion exchange resin, eluting with calcium ons |
08/27/1991 | US5043427 Fatty acid precipitating agent |
08/27/1991 | US5043426 Process for manufacturing organized collagen structures, particularly of human origin, and organized collagen structures corresponding thereto |
08/27/1991 | US5043425 Anticoagulants |
08/27/1991 | US5043424 Modification method for peptides and proteins by reacting with a phosphoric acid ester |
08/27/1991 | US5043422 Polypeptide; prevention, therapy aids |
08/27/1991 | US5043322 Cyclic GRF analogs |
08/27/1991 | US5043271 DNA encoding rabbit TNE, vector having said DNA inserted thereinto, host transformed with said vector, rabbit TNF polypeptide, and process for production thereof |
08/27/1991 | US5043262 Screening for HIV-1 virus |
08/27/1991 | US5043158 Immunogenic compositions containing ordered carriers |
08/27/1991 | US5043156 Method of treating infectious diseases with granulocyte colony-stimulating factor |
08/27/1991 | US5043101 Forming metal-transferrin and metal-dextran compounds, combining to form metal-transferrin-dextran |
08/27/1991 | CA2053895A1 Peptide derivatives and production thereof |
08/27/1991 | CA1288197C Metal ion labeling of carrier molecules |
08/27/1991 | CA1288196C Process for production of dry bioactive recombinant growth hormones |
08/27/1991 | CA1288195C Gnrh antagonists ix |
08/27/1991 | CA1288075C Fermentation methods for hepatitis vaccine production |
08/27/1991 | CA1288071C Color marker for clonings in streptomyces lividans |
08/27/1991 | CA1288046C Process for the separation of antifactor viii:c antibodies, more particularly usable for the purification of the blood plasma of a type a hemophiliac |
08/24/1991 | WO1991012815A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO β-LACTAM ANTIBIOTICS |
08/24/1991 | CA2076529A1 Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
08/23/1991 | WO1991013161A1 Antigenic proteins of plasmodium |
08/23/1991 | WO1991012784A1 Neuropeptide control of ocular growth |
08/23/1991 | CA2076035A1 Antigenic proteins of plasmodium |
08/23/1991 | CA2036815A1 Peptides which inhibit blood coagulation, processes for the preparation thereof and the use thereof |
08/23/1991 | CA2036093A1 Peptide fragments and analogs of thrombospondin |
08/22/1991 | WO1991012824A2 19f labelled compounds as nmr imaging and spectroscopy agents |
08/22/1991 | WO1991012817A1 Novel insulin compositions |
08/22/1991 | WO1991012529A1 E. HISTOLYTICA Gal/GalNAc LECTIN |
08/22/1991 | WO1991012340A1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
08/22/1991 | WO1991012334A1 Inhibitor of cytokine activity and applications thereof |
08/22/1991 | WO1991012330A1 Production of immunosuppressive factor |
08/22/1991 | WO1991012328A1 Totally synthetic affinity reagents |
08/22/1991 | WO1991012326A1 Dna segments and transformed microorganisms comprising the gene of delta1-dehydrogenase, and uses thereof |
08/22/1991 | WO1991012325A1 Htlv envelope antigenic segment |
08/22/1991 | WO1991012324A1 Novel human cyclin a compositions and their production method, a corresponding nucleotide sequence, a method and agents for detecting or diagnosing cell multiplication, and a method and agents for inhibiting cell multiplication |
08/22/1991 | WO1991012317A1 Lung cell line and methods of use |
08/22/1991 | WO1991012316A1 Method for preparing blood derivatives and derivatives thereby obtained |
08/22/1991 | WO1991012274A1 Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use |
08/22/1991 | WO1991012273A2 Methods of producing hybrid g protein-coupled receptors |
08/22/1991 | WO1991012272A1 Protein factor |
08/22/1991 | WO1991012271A1 Synthetic peptides for neutralizing the infectivity of the aids virus (hiv) |
08/22/1991 | WO1991012270A2 Novel platelet aggregation inhibitors from the leech |
08/22/1991 | WO1991012269A1 Immunologically active peptides or polypeptides from the parvovirus b19 |
08/22/1991 | WO1991012258A1 Retinoid receptor compositions and methods |
08/22/1991 | WO1991012018A1 Method for treating intestinal diseases |
08/22/1991 | WO1991012015A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell |
08/22/1991 | WO1991010736A3 CLONING AND CHARACTERIZATION OF THE CD3θ SUBUNIT |
08/22/1991 | WO1991009951A3 Recombinant protein c with truncated light chain |
08/22/1991 | DE4005062A1 Mammary-derived Growth Inhibitor peptide(s) - and antibodies useful in bio technology and medicine as proliferation inhibitors e.g. of carcinoma cells |
08/22/1991 | DE4003944A1 New synthetic polypeptide conjugate of LHRH and keyhole limpet haemocy - used to provide antibodies to hormone, for treating breast and prostate carcinoma etc. |
08/22/1991 | CA2075982A1 Insulin compositions |
08/22/1991 | CA2075953A1 19 f labelled compounds as nmr imaging and spectroscopy agents |
08/21/1991 | WO1991013356A1 Improved antibody-enzyme direct conjugates and method of making same |
08/21/1991 | EP0442724A2 Modified hIL-6 |
08/21/1991 | EP0442592A2 Plasmids for the production of transgenic plants altered in appearance and yield |
08/21/1991 | EP0442538A1 High purified protein, production and use thereof |
08/21/1991 | EP0442394A2 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines |
08/21/1991 | EP0441939A1 Wound healing |
08/21/1991 | EP0441897A1 Parvovirus capsids |
08/21/1991 | EP0441889A1 Modified human growth hormone |
08/21/1991 | EP0441884A1 Wound-induced dna sequence from solanum tuberosum and its use |
08/21/1991 | EP0441882A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides |
08/21/1991 | EP0441871A1 A sheet feeding apparatus |
08/21/1991 | EP0441832A1 Composition and treatment with biologically active peptides and certain anions. |
08/21/1991 | EP0441821A1 Probe for detection of the fragile x syndrome |
08/21/1991 | EP0403605A4 Elastase inhibiting polymers and methods |
08/21/1991 | EP0365657A4 Dna encoding androgen receptor protein |